ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 356

Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years

JUAN MARIA BLANCO MADRIGAL1,2, MARIA LUZ GARCIA VIVAR3, Eva Galindez-Agirregoikoa3, OLAIA BEGOÑA FERNANDEZ BERRIZBEITIA4, Itziar Calvo Zorrilla3, Edurne Guerrero Basterretxea3, Esther Ruíz Lucea5, Ignacio Torre Salaberri6, Lidia Estopiñán-Fortea3, Catalina Gómez Arango7 and Amaia Bilbao-González8, 1Rheumatology Department, Basurto University Hospital, VITORIA, Spain, 2Rheumatology, Rheumatology Department, Basurto University Hospital, VITORIA, Spain, 3Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 4Rheumatology Department, Basurto University Hospital, BILBAO, Spain, 5Rheumatology Department, Basurto University Hospital., Bilbao, Spain, 6Rheumatology, Hospital Universitario de Basurto. Bilbao., Bilbao, Spain, 7Rheumatology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 8Research Department, Basurto University Hospital, Bilbao, Spain

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: bone disease, Fracture risk, osteoporosis and risk management

Session Information

Date: Sunday, November 13, 2016

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis (OP) in males under 70 years is less common than postmenopausal and senile, but generates significant social and health costs associated with morbidity and mortality from fractures. It´s common in patients with inflammatory rheumatic diseases and hepatic, bowel and endocrine pathologies, also in COPD patients and in those undergoing chronic corticosteroid therapy. Sometimes clinical risk factors of male OP go unnoticed, so the diagnosis is delayed and is done when one or more fractures by low energy mechanism have already produced, which is a late diagnosis. Bone Metabolism Unit at Basurto University Hospital receives from 2010 male patients with suspected OP. The objective of this study is to describe demographic and clinical characteristics of men ≤70 years evaluated in our OP consultation, with referral protocols according to risk factors.

Methods: A retrospective, descriptive study based on a review of database of these patients. We analyze origin of derivation, risk factors, presence of fractures at the moment of diagnosis, primary diagnoses and occurrence of refractures. All statistical analyses were performed using SAS for Windows statistical software, version 9.2.

Results: 199 patients, with a mean age of 57.74 years (18-70), from Primary Care (73), and general rheumatology (57), up to 65% of the total; 23 patients (11.5%) from traumatology; 15 from endocrinology (7.5%); 9 from gastroenterology (4.5%). 59.8% were smokers or former smokers, 25% had drinking habit. 20.1% had received prednisone doses ≥ 7.5 mg for more than 3 months. 12 patients had family history of fracture (6%), and 70 already had one or more fractures (35.1%): 57 one or more vertebral fractures, 5 hip fracture and 12 wrist fracture. 99 patients had OP with treatment indication by bone agent. 59.3% had secondary OP, main cause digestive disorders (malabsorption syndromes and inflammatory bowel disease) by 21%, 10% endocrine disorders and rheumatic inflammatory diseases also by 10%. Presence of fractures was associated with decreased DXA spine (p = 0.027) and hip (p = 0.004). A very weak correlation between higher FRAX fracture and number of risk factors was detected, on the other hand a moderate correlation was observed with the number of fractures (Spearman Rho = 0.472; p <0.001). So does to the hip FRAX (Spearman Rho = 0.417; p <0.001). Low levels of D vitamin showed association with decreased DXA in spine. Drinking habit showed statistically significant association (p=0.032) with a decrease in the T – score of hip. Among 70 patients with previous fractures, only 15 (21%) had received prior treatment with bone agent. 7 patients suffered refracture after starting treatment and during follow-up (74.2 months) (6-129).

Conclusion: For the correlation found with spine bone density, it seems important to keep enough D vitamin levels in this population. Almost 1/3 of our patients were referred for low energy mechanism fractures, which is an important failure in early diagnosis, and reveals an unmet need among different specialties of awareness on risk factors for male osteoporosis. Therapy with bone agent (oral biphosphonate mainly), seems useful in preventing new bone fractures in these patients.


Disclosure: J. M. BLANCO MADRIGAL, None; M. L. GARCIA VIVAR, None; E. Galindez-Agirregoikoa, None; O. B. FERNANDEZ BERRIZBEITIA, None; I. Calvo Zorrilla, None; E. Guerrero Basterretxea, None; E. Ruíz Lucea, None; I. Torre Salaberri, None; L. Estopiñán-Fortea, None; C. Gómez Arango, None; A. Bilbao-González, None.

To cite this abstract in AMA style:

BLANCO MADRIGAL JM, GARCIA VIVAR ML, Galindez-Agirregoikoa E, FERNANDEZ BERRIZBEITIA OB, Calvo Zorrilla I, Guerrero Basterretxea E, Ruíz Lucea E, Torre Salaberri I, Estopiñán-Fortea L, Gómez Arango C, Bilbao-González A. Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/osteoporotic-fracture-as-the-main-risk-factor-in-the-detection-of-osteoporosis-in-men-under-70-years/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/osteoporotic-fracture-as-the-main-risk-factor-in-the-detection-of-osteoporosis-in-men-under-70-years/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology